Advertisement

Migraine/Headache

Authoritative medical articles, news, research, and guidelines pertaining to Migraine/Headache.

FDA Approves Ubrelvy for Acute Migraine Treatment

Significantly more patients treated with Ubrelvy versus placebo achieved pain freedom two hours post-treatment TUESDAY, Dec. 24, 2019 (HealthDay News) -- Ubrelvy (ubrogepant) tablets ha...

FDA Approves Ubrelvy for Acute Migraine Treatment
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement